CASE REPORT
Published on 12 Feb 2025
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
doi 10.3389/fimmu.2025.1544604
- 573 views
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Advances in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers, Volume II
Advances in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers, Volume II
818
Total downloads
2,617
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.